SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:oru-55788"
 

Search: onr:"swepub:oai:DiVA.org:oru-55788" > Change in Gait Devi...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Broström, E WKarolinska Institutet (author)

Change in Gait Deviation Index after anti-tumour necrosis factor-α treatment in individuals with rheumatoid arthritis : a pilot study

  • Article/chapterEnglish2013

Publisher, publication year, extent ...

  • 2013-04-14
  • Informa Healthcare,2013
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:oru-55788
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-55788URI
  • https://doi.org/10.3109/03009742.2013.776102DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:127385208URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding Agencies:Research foundations Promobilia Karolinska Institutet FoundationsDevelopmental foundation of the footwear industry
  • OBJECTIVES: Anti-tumour necrosis factor-alpha (TNF-α) inhibitors provide fast, effective resolution of rheumatoid arthritis (RA) inflammation. In this study we aimed to quantify the impact of TNF-α treatment on gait dynamics.METHOD: The sample comprised 16 subjects [11 female, median age 56 (range 48-66) years, median disease duration 9.5 (range 4.6-20.6) years] with RA who met the American College of Rheumatology (ACR) criteria, had lower extremity involvement, did not use walking aids, and had started TNF-α treatment within 1 week of baseline gait analysis. Gait analysis focused on three-dimensional (3D) lower extremity joint kinematics, kinetics, time and distance parameters. The Gait Deviation Index (GDI) and GDI-Kinetic were calculated. Data on gait, disease activity, and physical disability were collected at baseline and at 3.5 months.RESULTS: Following treatment with TNF-α, statistically significant improvements were found in disease activity [using the 28-joint Disease Activity Score based on C-reactive protein (DAS28-CRP); median difference (m(d)) = 2.3, p < 0.01], physical disability [Health Assessment Questionnaire (HAQ) m(d) = 0.4, p < 0.01], and pain during walking [visual analogue scale (VAS) m(d) = 11.0, p < 0.05]. Reductions in gait deviations were noted (GDI m(d) = 3.7, p = 0.04; GDI-Kinetic m(d) = 4.1, p = 0.05) along with reductions in dimensionless time and distance parameters. A moderate to good negative correlation existed between baseline GDI and GDI change scores (r(s) = -0.7, p < 0.01).CONCLUSIONS: Treatment with TNF-α improved gait dynamics in adults with RA. Significant gait deviations were, however, still present after treatment. In this study, GDI and GDI-Kinetic scores appeared to be useful outcome measures to quantify changes in gait deviations after this intervention.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Esbjörnsson, A-CKarolinska Institutet (author)
  • von Heideken, JKarolinska Institutet (author)
  • Larsson, PKarolinska Institutet (author)
  • Wretenberg, Per,1963-Karolinska Institutet,Region Örebro län,Department of Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden(Swepub:oru)pewg (author)
  • Iversen, MKarolinska Institutet (author)
  • Region Örebro länKarolinska Institutet (creator_code:org_t)

Related titles

  • In:Scandinavian Journal of Rheumatology: Informa Healthcare42:5, s. 356-3610300-97421502-7732

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view